Pseudomonas aeruginosaKeratitis: Outcomes and Response to Corticosteroid Treatment
Investigative Ophthalmology & Visual Science2011Vol. 53(1), pp. 267–267
Citations Over TimeTop 10% of 2011 papers
Aileen Sy, Muthiah Srinivasan, Jeena Mascarenhas, Prajna Lalitha, Revathi Rajaraman, Meenakshi Ravindran, Catherine E. Oldenburg, Kathryn J. Ray, David V. Glidden, Michael E. Zegans, Stephen D. McLeod, Thomas M. Lietman, Nisha R. Acharya
Abstract
Although P. aeruginosa corneal ulcers have a more severe presentation, they appear to respond better to treatment than other bacterial ulcers. The authors did not find a significant benefit with corticosteroid treatment, but they also did not find any increase in adverse events. (ClinicalTrials.gov number, NCT00324168.).
Related Papers
- → Comparative Efficacy of Topical Moxifloxacin Versus Ciprofloxacin and Vancomycin in the Treatment of P. aeruginosa and Ciprofloxacin-Resistant MRSA Keratitis in Rabbits(2005)37 cited
- → Quantitative comparison of fluoroquinolone therapies of experimental Gram-negative bacterial keratitis(2004)25 cited
- → Increased level of (1,3)-β-D-glucan in tear fluid of mycotic keratitis(2009)9 cited
- → Association Between Moxifloxacin Ophthalmic Solution and Fungal Infection in Patients With Corneal Ulcers and Microbial Keratitis(2009)8 cited
- → Fungal keratitis in patients with corneal ulcer referred to Boo Ali Sina Hospital, Sari, Northern Iran (2004–5)(2007)